vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and MetroCity Bankshares, Inc. (MCBS). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $43.7M, roughly 1.9× MetroCity Bankshares, Inc.). MetroCity Bankshares, Inc. runs the higher net margin — 50.5% vs 6.8%, a 43.7% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 23.6%). MetroCity Bankshares, Inc. produced more free cash flow last quarter ($37.0M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Metro City Bank is a Korean-American bank based in Doraville, Georgia and offers personal and commercial banking services. It is the largest Korean-American bank to not be based out of Los Angeles, California. It currently operates a total of 19 branches in Texas, New York, New Jersey, Virginia, Georgia, Alabama, and Florida.
BLLN vs MCBS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $43.7M |
| Net Profit | $5.7M | $18.1M |
| Gross Margin | 69.9% | — |
| Operating Margin | 11.5% | 52.8% |
| Net Margin | 6.8% | 50.5% |
| Revenue YoY | 117.4% | 23.6% |
| Net Profit YoY | 138.3% | 11.7% |
| EPS (diluted) | $0.10 | $0.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $43.7M | ||
| Q3 25 | $83.5M | $38.0M | ||
| Q2 25 | — | $37.9M | ||
| Q1 25 | — | $36.0M | ||
| Q4 24 | $45.1M | $35.4M | ||
| Q3 24 | $38.4M | $36.9M | ||
| Q2 24 | — | $36.3M | ||
| Q1 24 | — | $32.7M |
| Q4 25 | — | $18.1M | ||
| Q3 25 | $5.7M | $17.3M | ||
| Q2 25 | — | $16.8M | ||
| Q1 25 | — | $16.3M | ||
| Q4 24 | $-11.5M | $16.2M | ||
| Q3 24 | $-14.9M | $16.7M | ||
| Q2 24 | — | $16.9M | ||
| Q1 24 | — | $14.6M |
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 52.8% | ||
| Q3 25 | 11.5% | 62.8% | ||
| Q2 25 | — | 62.4% | ||
| Q1 25 | — | 61.3% | ||
| Q4 24 | 17.0% | 58.9% | ||
| Q3 24 | -32.9% | 61.4% | ||
| Q2 24 | — | 64.4% | ||
| Q1 24 | — | 62.6% |
| Q4 25 | — | 50.5% | ||
| Q3 25 | 6.8% | 45.5% | ||
| Q2 25 | — | 44.4% | ||
| Q1 25 | — | 45.3% | ||
| Q4 24 | -25.5% | 54.0% | ||
| Q3 24 | -38.8% | 45.3% | ||
| Q2 24 | — | 46.7% | ||
| Q1 24 | — | 44.8% |
| Q4 25 | — | $0.69 | ||
| Q3 25 | $0.10 | $0.67 | ||
| Q2 25 | — | $0.65 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | $-1.13 | $0.64 | ||
| Q3 24 | $-1.47 | $0.65 | ||
| Q2 24 | — | $0.66 | ||
| Q1 24 | — | $0.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $383.7M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $544.2M |
| Total Assets | $327.5M | $4.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $383.7M | ||
| Q3 25 | $195.2M | $227.2M | ||
| Q2 25 | — | $286.0M | ||
| Q1 25 | — | $285.1M | ||
| Q4 24 | $191.5M | $249.9M | ||
| Q3 24 | — | $291.2M | ||
| Q2 24 | — | $327.9M | ||
| Q1 24 | — | $258.8M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $544.2M | ||
| Q3 25 | $-239.5M | $445.9M | ||
| Q2 25 | — | $436.1M | ||
| Q1 25 | — | $428.0M | ||
| Q4 24 | $-251.7M | $421.4M | ||
| Q3 24 | $-242.9M | $407.2M | ||
| Q2 24 | — | $407.2M | ||
| Q1 24 | — | $396.6M |
| Q4 25 | — | $4.8B | ||
| Q3 25 | $327.5M | $3.6B | ||
| Q2 25 | — | $3.6B | ||
| Q1 25 | — | $3.7B | ||
| Q4 24 | $302.1M | $3.6B | ||
| Q3 24 | — | $3.6B | ||
| Q2 24 | — | $3.6B | ||
| Q1 24 | — | $3.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $37.7M |
| Free Cash FlowOCF − Capex | $6.5M | $37.0M |
| FCF MarginFCF / Revenue | 7.7% | 84.7% |
| Capex IntensityCapex / Revenue | 8.8% | 1.5% |
| Cash ConversionOCF / Net Profit | 2.42× | 2.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $79.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $37.7M | ||
| Q3 25 | $13.8M | $16.5M | ||
| Q2 25 | — | $14.5M | ||
| Q1 25 | — | $11.9M | ||
| Q4 24 | — | $63.5M | ||
| Q3 24 | — | $-11.5M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $36.4M |
| Q4 25 | — | $37.0M | ||
| Q3 25 | $6.5M | $16.2M | ||
| Q2 25 | — | $14.3M | ||
| Q1 25 | — | $11.8M | ||
| Q4 24 | — | $62.2M | ||
| Q3 24 | — | $-11.8M | ||
| Q2 24 | — | $19.0M | ||
| Q1 24 | — | $36.1M |
| Q4 25 | — | 84.7% | ||
| Q3 25 | 7.7% | 42.7% | ||
| Q2 25 | — | 37.8% | ||
| Q1 25 | — | 32.9% | ||
| Q4 24 | — | 175.8% | ||
| Q3 24 | — | -31.9% | ||
| Q2 24 | — | 52.4% | ||
| Q1 24 | — | 110.6% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | 8.8% | 0.7% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 0.7% |
| Q4 25 | — | 2.08× | ||
| Q3 25 | 2.42× | 0.95× | ||
| Q2 25 | — | 0.86× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | — | 3.91× | ||
| Q3 24 | — | -0.69× | ||
| Q2 24 | — | 1.14× | ||
| Q1 24 | — | 2.49× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
MCBS
Segment breakdown not available.
